SequelSEC

Aveanna Healthcare Holdings, Inc. AVAH

Services-Home Health Care Services · CIK 0001832332 · Fiscal year ends 0101

AnnualQuarterlyTTM
Revenue
$2.43B
Fiscal year ended 2026-01-03
Operating income
$256.46M
Fiscal year ended 2026-01-03
Free cash flow
Unavailable
Fiscal year ended 2026-01-03

Valuation, from the filing

Public float$349.70MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-28
Float per share$1.61Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / net income1.6×A lower bound on the multiple, because affiliate holdings are excluded.
Float / revenue0.1×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity1.8×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-28, not today, and each multiple below it uses the figures for the fiscal year ending 2026-01-03 — the year that filing covered.

How this compares in its industry

Percentile among the Services-Home Health Care Services filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Long-term debt / equity6.62x100th
Effective tax rate-110.4%0th
Gross margin33.3%100th
Net margin9.2%80th
Operating margin10.5%80th
SBC / revenue1.0%75th
Revenue YoY growth20.2%60th
Current ratio1.32x50th

Aveanna Healthcare Holdings, Inc. (AVAH) reported revenue of $2.43B and net income of $225.03M for the fiscal year ended 2026-01-03. This page shows 7 annual periods of income statement, balance sheet and cash flow figures normalized from Aveanna Healthcare Holdings, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Home Health Care Services.

Income

Aveanna Healthcare Holdings, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-01-032024-12-282023-12-302022-12-312022-01-012021-01-022019-12-28
Revenue$2.43B$2.02B$1.90B$1.79B$1.68B$1.50B$1.38B
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross profit$810.48M$635.54M$595.43M$553.23M$542.40M$454.52M$419.25M
Operating income$256.46M$139.79M$8.07M-$642.28M-$36.11M-$3.49M$38.95M
Net income$225.03M-$10.93M-$134.52M-$662.03M-$117.04M-$57.05M-$76.52M
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 214.98Mshares 192.89Mshares 189.96Mshares 185.55MUnavailableUnavailableUnavailable
Pretax income$106.95M$5.07M-$139.00M-$663.81M-$113.58M-$51.73M-$75.03M
Income tax expense-$118.09M$16.00M-$4.47M-$1.78M$3.47M$5.32M$1.49M
Diluted EPS$1.05$-0.06$-0.71$-3.57$-0.69UnavailableUnavailable
Selling, general & administrative$374.50M$352.81M$360.98M$357.23M$297.38M$240.95M$227.76M
General & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

Aveanna Healthcare Holdings, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-01-032024-12-282023-12-302022-12-312022-01-012021-01-022019-12-28
Cash & equivalents$193.26M$84.29M$43.94M$19.22M$30.49M$137.34MUnavailable
Total assets$2.01B$1.66B$1.61B$1.71B$2.33B$1.84BUnavailable
Current assets$560.23M$392.67M$314.89M$269.75M$279.22M$340.64MUnavailable
Total liabilities$1.82B$1.79B$1.74B$1.72B$1.70B$1.58BUnavailable
Current liabilities$424.46M$402.17M$354.76M$326.50M$344.83M$260.41MUnavailable
Total equity incl. NCI$194.46M-$123.55M-$129.57M-$6.31M$635.82M$265.03M$270.19M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
InventoryUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivable$313.36M$265.19M$236.56M$221.24M$218.92M$172.89MUnavailable
Goodwill$1.12B$1.05B$1.05B$1.16B$1.84B$1.32B$1.23B
Long-term debt$1.29B$1.27B$1.28B$1.28B$1.23B$1.16BUnavailable
Accounts payableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Cash flow

Aveanna Healthcare Holdings, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-01-032024-12-282023-12-302022-12-312022-01-012021-01-022019-12-28
Operating cash flow$125.86M$32.64M$22.67M-$48.40M-$11.35M$116.62M-$8.71M
Capital expendituresUnavailableUnavailableUnavailableUnavailable$15.95M$15.24M$16.64M
Investing cash flow-$22.30M-$6.32M-$8.79M-$25.29M-$681.83M-$193.54M-$17.82M
Financing cash flow$5.41M$14.03M$10.85M$62.42M$586.33M$210.94M$21.86M
Net change in cash$108.97M$40.35M$24.72M-$11.27M-$106.86M$134.02M-$4.67M
Stock-based compensation$25.06M$17.46M$13.16M$15.89M$14.42M$3.28M$1.95M
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$10.54M$10.78M$13.78M$21.31M$20.55M$17.03M$14.32M

Derived

Aveanna Healthcare Holdings, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-01-032024-12-282023-12-302022-12-312022-01-012021-01-022019-12-28
Free cash flowUnavailableUnavailableUnavailableUnavailableUnavailable$101.38M-$25.35M
Gross margin33.3%31.4%31.4%30.9%32.3%30.4%30.3%
Operating margin10.5%6.9%0.4%-35.9%-2.2%-0.2%2.8%
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailable6.8%-1.8%
SBC / revenue1.0%0.9%0.7%0.9%0.9%0.2%0.1%
Current ratio1.32x0.98x0.89x0.83x0.81x1.31xUnavailable
Revenue YoY growth20.2%6.8%6.0%6.5%12.3%8.0%Unavailable
Net margin9.2%-0.5%-7.1%-37.0%-7.0%-3.8%-5.5%
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailable1.0%1.2%
Long-term debt / equity6.62xUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rate-110.4%315.5%UnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open AVAH in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-13View SEC filing
10-Q · Filed 2026-05-14View SEC filing
10-K · Filed 2026-03-19View SEC filing
10-Q · Filed 2025-11-06View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-08View SEC filing

Companies in the same industry

ADUS AHCO BTSG CHE EDGM OPCH

Reconciliation checks needing review

3 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

balance equationreview2023-12-30

Difference 2135000 exceeds tolerance 1612985.000. Presentation or filing-vintage differences need review.

balance equationreview2022-12-31

Difference 2135000 exceeds tolerance 1711760.000. Presentation or filing-vintage differences need review.

balance equationreview2021-01-02

Difference 2135000 exceeds tolerance 1844016.000. Presentation or filing-vintage differences need review.